NHS backs new treatment option for cystinosis

Regulatoryapproveddelayed-release mercaptaminePositive

AI Analysis

Summary

The NHS has approved delayed-release mercaptamine for routine use as a treatment option for cystinosis. This regulatory approval expands treatment availability for patients with this rare genetic disorder.

Outcome Details

NHS approved delayed-release mercaptamine for routine use in cystinosis

Importance:6/10

Sentiment:

0.70

regulatory approvalNHScystinosismercaptaminerare disease

Related Companies

$OPTN

Read the original article

Published by PharmaTimes on August 12, 2026 9:30 AM

Read Original